Literature DB >> 26054451

In vitro inhibitory activities of six gypenosides on human liver cancer cell line HepG2 and possible role of HIF-1α pathway in them.

Lin Shi1, Yuzhen Pi2, Cheng Luo3, Chunhong Zhang2, Dehong Tan4, Xianjun Meng5.   

Abstract

During our phytochemical investigation of Gynostemma pentaphyllum (Thunb.) Makino, six gypenosides (compounds 1-6) were isolated and determined, including two with a 21,23-epoxy group (1, 2), two with a 21,23-lacton skeleton (3, 4), and two with usual side-chain (5, 6). In this research, we studied their possible in vitro inhibitory activities on cancer cell line HepG2 under hypoxic conditions, explored the role of HIF-1α pathway in them and discussed the potential antitumor gradients and conduct analysis of structure-activity relationships (SAR). They and gensenoside-Rg3 were tested for different assays. Compounds 1-4 showed moderate antitumor activities against HepG2 by MTT assay, inhibited HIF-1α mRNA expression, as well as disturbing HepG2 migration and invasion, superior to Rg3. Correlations were found for gypenosides with different side chain on inhibiting HepG2 proliferation activity, the ones have epoxy structure showed the highest effect. These results supported the potential application of G. pentaphyllum as a functional food for hepatoprotection.
Copyright © 2015 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Keywords:  Cytotoxic activity; Gynostemma pentaphyllum; Gypenosides; HIF-1α; HepG2

Mesh:

Substances:

Year:  2015        PMID: 26054451     DOI: 10.1016/j.cbi.2015.06.004

Source DB:  PubMed          Journal:  Chem Biol Interact        ISSN: 0009-2797            Impact factor:   5.192


  5 in total

1.  Antioxidant and antitumor effects of ferula sinkiangensis K. M. Shen.

Authors:  Haiying Zhang; Jun Lu; Longlong Zhou; Lin Jiang; Mingxin Zhou
Journal:  Int J Clin Exp Med       Date:  2015-11-15

Review 2.  Anti-cancer effects of Gynostemma pentaphyllum (Thunb.) Makino (Jiaogulan).

Authors:  Yantao Li; Wanjun Lin; Jiajun Huang; Ying Xie; Wenzhe Ma
Journal:  Chin Med       Date:  2016-09-27       Impact factor: 5.455

3.  Formulation design, characterization, and in vitro and in vivo evaluation of nanostructured lipid carriers containing a bile salt for oral delivery of gypenosides.

Authors:  Gang Yang; Feihua Wu; Minyan Chen; Jian Jin; Rong Wang; Yongfang Yuan
Journal:  Int J Nanomedicine       Date:  2019-04-01

4.  Gypenoside-Induced Apoptosis via the PI3K/AKT/mTOR Signaling Pathway in Bladder Cancer.

Authors:  Xiuming Li; Hui Liu; Chengcheng Lv; Jun Du; Fangchao Lian; Shouyi Zhang; Zhiyong Wang; Yu Zeng
Journal:  Biomed Res Int       Date:  2022-03-29       Impact factor: 3.411

5.  Gypenoside Attenuates β Amyloid-Induced Inflammation in N9 Microglial Cells via SOCS1 Signaling.

Authors:  Hui Cai; Qianlei Liang; Guanqun Ge
Journal:  Neural Plast       Date:  2016-04-26       Impact factor: 3.599

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.